Astellas pharma announced today that the U.S. Food and Drug Administration (FDA) has approved Astagraf XL (tacrolimus extended-release capsules) for the prophylaxis of organ rejection in patients receiving a kidney transplant with
Astellas Pharma - Wikidata
Astellas continues IT-enabled drug repurposing deal drive with Excelra hookup | Fierce Biotech
Accenture builds advanced cloud-based IT core platform for Astellas
Pfizer to buy Medivation for $14 billion | Zee Business
Robert | Wikinamia - The Name Wiki Encyclopedia Wiki | Fandom
Big Pharma share prices jumped in the first half, except for BMS | Fierce Pharma
File:Astellas Pharma Inc. Miyukigaoka Research Center.jpg - Wikimedia Commons